Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 548.25B | 575.66B | 555.96B | 479.08B | 389.71B | 410.96B |
Gross Profit | 198.67B | 209.10B | 192.01B | 168.65B | 116.37B | 124.50B |
EBITDA | 76.44B | 86.55B | 83.17B | 70.19B | 42.14B | 40.22B |
Net Income | 44.31B | 50.69B | 51.78B | 38.35B | 18.93B | 15.57B |
Balance Sheet | ||||||
Total Assets | 706.99B | 702.34B | 653.13B | 559.04B | 487.43B | 450.13B |
Cash, Cash Equivalents and Short-Term Investments | 56.85B | 44.69B | 46.74B | 57.23B | 52.91B | 41.96B |
Total Debt | 105.33B | 95.90B | 99.56B | 68.04B | 76.54B | 81.58B |
Total Liabilities | 296.83B | 294.32B | 298.06B | 260.94B | 237.87B | 218.96B |
Stockholders Equity | 402.03B | 399.34B | 347.50B | 291.23B | 246.27B | 228.36B |
Cash Flow | ||||||
Free Cash Flow | 20.30B | 23.59B | -24.14B | 25.01B | 30.99B | -845.00M |
Operating Cash Flow | 59.90B | 54.62B | -2.21B | 49.23B | 39.60B | 21.48B |
Investing Cash Flow | -28.59B | -29.35B | -19.69B | -24.16B | -9.60B | -20.64B |
Financing Cash Flow | -18.72B | -29.42B | 7.20B | -22.48B | -20.28B | 491.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $141.74B | 36.56 | 20.84% | 1.15% | 7.00% | 16.84% | |
80 Outperform | $154.50B | 27.61 | 33.56% | 1.88% | 6.30% | 0.81% | |
76 Outperform | $78.61B | 33.36 | 9.82% | 1.51% | 6.49% | 24.14% | |
69 Neutral | $39.12B | 43.70 | 25.86% | 1.51% | -11.19% | -22.50% | |
68 Neutral | $35.09B | 43.00 | 8.09% | 0.09% | 5.27% | 0.61% | |
68 Neutral | €2.80B | 17.63 | 9.89% | 2.89% | -0.64% | -28.31% | |
61 Neutral | $5.77B | 15.35 | 13.09% | 1.32% | -11.88% | 15.55% |